New York, NY & Tel Aviv, Israel, Sept. 19, 2021 (GLOBE NEWSWIRE) — (by way of Blockchain Wire) Todos Medical, Ltd. (OTCQB: TOMDF), a medical diagnostics and options firm with complete product choices, introduced that it’s now accepting Bitcoin (BTC), Ethereum (ETH), Dogecoin (DOGE), Bitcoin Money (BCH) and Litecoin (LTC) as fee for the Firm’s proprietary 3CL protease inhibitor wellness merchandise Tollovid® and Tollovid Every day™. The Firm is ready to settle for these types of funds by means of its www.mytollovid.com web site when purchasers choose Coinbase Commerce because the type of fee at checkout.
“We imagine strongly that everybody ought to take Tollovid to assist their immune operate throughout occasions of great immune problem and must be taking Tollovid Every day every day so as to preserve constant, wholesome immune operate,” stated Gerald E. Commissiong, President & CEO of Todos Medical. “The flexibility to simply accept broadly utilized cryptocurrency is a crucial step as we broaden our advertising and marketing efforts round our novel 3CL protease inhibitor wellness merchandise.”
Tollovid and Tollovid Every day are dietary complement merchandise which have each acquired Certificates of Free Sale from the U.S. Meals & Drug Administration (FDA), authorizing the advertising and marketing and sale of those merchandise in the USA. The FDA has allowed the Firm to make two particular claims as regards to every product:
- Tollovid and Tollovid Every day assist to assist and preserve wholesome immune operate; and
- Tollovid and Tollovid Every day are 3CL protease inhibitors.
Tollovid is focused to clients that want most immune assist, whereas Tollovid Every day addresses clients that require or may benefit from every day immune assist. Each Tollovid and Tollovid Every day may be bought by way of subscription and now, using cryptocurrency
About Todos Medical Ltd.
Based in Rehovot, Israel with places of work in New York Metropolis, Todos Medical Ltd. (OTCQB: TOMDF) engineers life-saving diagnostic options for the early detection of quite a lot of cancers. In 20201, Todos accomplished the acquisition of U.S.-based medical diagnostics firm Provista Diagnostics, Inc. to realize rights to its Alpharetta, Georgia-based CLIA/CAP licensed lab at present performing PCR COVID testing and Provista’s proprietary commercial-stage Videssa® breast most cancers blood check. The Firm’s state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening know-how utilizing peripheral blood evaluation that deploys deep examination into most cancers’s affect on the immune system, searching for biochemical adjustments in blood mononuclear cells and plasma. Todos’ two internally-developed cancer-screening exams, TMB-1 and TMB-2, have acquired a CE mark in Europe. Todos is targeted on the commercialization of Videssa and can convey the TBIA exams to market thereafter.
Todos has entered right into a three way partnership with NLC Pharma focusing on diagnostic and testing options to handle the COVID-19 pandemic. The Joint-Enterprise is pursuing the event of diagnostic exams focusing on the 3CL protease, in addition to 3CL protease inhibitors that concentrate on a basic reproductive mechanism of coronaviruses. The Firm’s proprietary therapeutic candidate Tollovir™ is at present in a Section 2 scientific trial to deal with hospitalized COVID-19 sufferers in Israel, and is making ready to provoke Section 2/3 scientific trials for each hospitalized and non-hospitalized sufferers in Israel.
Todos can also be growing blood exams for the early detection of neurodegenerative problems, similar to Alzheimer’s illness. The Lymphocyte Proliferation Check (LymPro Check™) is a diagnostic blood check that determines the flexibility of peripheral blood lymphocytes (PBLs) and monocytes to face up to an exogenous mitogenic stimulation that induces them to enter the cell cycle. It’s believed that sure illnesses, most notably Alzheimer’s illness, are the results of compromised mobile equipment that results in aberrant cell cycle re-entry by neurons, which then results in apoptosis. LymPro is exclusive in the usage of peripheral blood lymphocytes as a surrogate for neuronal cell operate, suggesting a standard relationship between PBLs and neurons within the mind.
Todos can also be distributing sure (COVID-19) testing supplies and provides to CLIA-certified labs in the USA. The merchandise cowl a number of suppliers of PCR testing kits, extraction kits, automation supplies and provides, in addition to COVID-19 antibody and antigen testing kits.
For extra data, please go to https://www.todosmedical.com
Sure statements contained on this press launch could represent forward-looking statements. For instance, forward-looking statements are used when discussing our anticipated scientific improvement applications and scientific trials. These forward-looking statements are primarily based solely on present expectations of administration, and are topic to vital dangers and uncertainties that would trigger precise outcomes to vary materially from these described within the forward-looking statements, together with the dangers and uncertainties associated to the progress, timing, price, and outcomes of scientific trials and product improvement applications; difficulties or delays in acquiring regulatory approval or patent safety for product candidates; competitors from different biotechnology firms; and our capability to acquire further funding required to conduct our analysis, improvement and commercialization actions. As well as, the next elements, amongst others, may trigger precise outcomes to vary materially from these described within the forward-looking statements: adjustments in know-how and market necessities; delays or obstacles in launching our scientific trials; adjustments in laws; incapacity to well timed develop and introduce new applied sciences, merchandise and purposes; lack of validation of our know-how as we progress additional and lack of acceptance of our strategies by the scientific neighborhood; incapacity to retain or entice key staff whose data is important to the event of our merchandise; unexpected scientific difficulties that will develop with our course of; better price of ultimate product than anticipated; lack of market share and strain on pricing ensuing from competitors; and laboratory outcomes that don’t translate to equally good ends in actual settings, all of which may trigger the precise outcomes or efficiency to vary materially from these contemplated in such forward-looking statements. Besides as in any other case required by regulation, Todos Medical doesn’t undertake any obligation to publicly launch any revisions to those forward-looking statements to replicate occasions or circumstances after the date hereof or to replicate the incidence of unanticipated occasions. For a extra detailed description of the dangers and uncertainties affecting Todos Medical, please discuss with its stories filed every so often with the U.S. Securities and Trade Fee.